Marker Therapeutics (($MRKR)) announced an update on their ongoing clinical study. Marker Therapeutics is conducting a Phase 1 study titled ‘A ...

Lynch Syndrome (LS) is a common hereditary condition that greatly increases lifetime risk of colorectal, endometrial, urothelial and other ...

Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main ...

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma ...

A new way of delivering vaccines using nanoparticles could prevent or slow down a number of different cancers in mice.

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

In a dedicated lab at Yale University and a data center deep inside Google DeepMind, a team of researchers may have just ...